BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 17483861)

  • 1. Pars plana vitrectomy and internal limiting membrane peeling for macular oedema secondary to retinal vein occlusion: a pilot study.
    Liang XL; Chen HY; Huang YS; Au Eong KG; Yu SS; Liu X; Yan H
    Ann Acad Med Singap; 2007 Apr; 36(4):293-7. PubMed ID: 17483861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pars plana vitrectomy with ILM peeling for macular edema secondary to retinal vein occlusion.
    Raszewska-Steglinska M; Gozdek P; Cisiecki S; Michalewska Z; Michalewski J; Nawrocki J
    Eur J Ophthalmol; 2009; 19(6):1055-62. PubMed ID: 19882567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term effects of vitrectomy and internal limiting membrane peeling for macular edema secondary to central retinal vein occlusion and hemiretinal vein occlusion.
    Park DH; Kim IT
    Retina; 2010 Jan; 30(1):117-24. PubMed ID: 19996831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Possible effects of internal limiting membrane peeling in vitrectomy for macular vein occlusion.
    Kumagai K; Furukawa M; Ogino N; Larson E
    Jpn J Ophthalmol; 2010 Jan; 54(1):61-5. PubMed ID: 20151278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vitrectomy with removal of the internal limiting membrane in chronic diabetic macular oedema.
    Dillinger P; Mester U
    Graefes Arch Clin Exp Ophthalmol; 2004 Aug; 242(8):630-7. PubMed ID: 15221304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pars plana vitrectomy, internal limiting membrane peeling, and panretinal endophotocoagulation for macular edema secondary to central retinal vein occlusion.
    DeCroos FC; Shuler RK; Stinnett S; Fekrat S
    Am J Ophthalmol; 2009 Apr; 147(4):627-633.e1. PubMed ID: 19193361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Vitrectomy with peeling retinal limiting membrane (ILM) in eyes with diabetic macular edema].
    Oficjalska-Młyńczak J; Jamrozy-Witkowska A; Muzyka-Woźniak M; Turno-Krecicka A; Gołebiowska B
    Klin Oczna; 2006; 108(7-9):273-7. PubMed ID: 17290822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LONG-TERM OUTCOMES OF 23-GAUGE PARS PLANA VITRECTOMY WITH INTERNAL LIMITING MEMBRANE PEELING AND GAS TAMPONADE FOR MYOPIC TRACTION MACULOPATHY: A Prospective Study.
    Figueroa MS; Ruiz-Moreno JM; Gonzalez del Valle F; Govetto A; de la Vega C; Plascencia RN; Contreras I; Medina JL
    Retina; 2015 Sep; 35(9):1836-43. PubMed ID: 25946689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Internal limiting membrane peeling for decompression of macular edema in retinal vein occlusion: a report of 14 cases.
    Mandelcorn MS; Nrusimhadevara RK
    Retina; 2004 Jun; 24(3):348-55. PubMed ID: 15187654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema.
    Avci R; Kaderli B; Avci B; Simsek S; Baykara M; Kahveci Z; Gelisken O; Yucel AA
    Graefes Arch Clin Exp Ophthalmol; 2004 Oct; 242(10):845-52. PubMed ID: 15221309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic factors influence the prognosis of diabetic macular edema after pars plana vitrectomy with internal limiting membrane peeling.
    Yamada Y; Suzuma K; Kumagami T; Fujikawa A; Kitaoka T
    Ophthalmologica; 2013; 229(3):142-6. PubMed ID: 23257613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical macular decompression for macular edema in retinal vein occlusion.
    Mandelcorn MS; Mandelcorn E; Guan K; Adatia FA
    Can J Ophthalmol; 2007 Feb; 42(1):116-22. PubMed ID: 17361252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 25-gauge vitrectomy and triamcinolone acetonide-assisted internal limiting membrane peeling for chronic cystoid macular edema associated with branch retinal vein occlusion.
    Ma J; Yao K; Zhang Z; Tang X
    Retina; 2008; 28(7):947-56. PubMed ID: 18698296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparison of pars plana vitrectomy with ILM peeling and intravitreal triamcinolone in diffuse diabetic macular oedema].
    Khurieva-Sattler E; Krause M; Löw U; Gatzioufas Z; Toropygin S; Seitz B; Ruprecht K; Hille K
    Klin Monbl Augenheilkd; 2010 Jun; 227(6):496-500. PubMed ID: 20221984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early postoperative retinal thickness changes and complications after vitrectomy for diabetic macular edema.
    Yamamoto T; Hitani K; Tsukahara I; Yamamoto S; Kawasaki R; Yamashita H; Takeuchi S
    Am J Ophthalmol; 2003 Jan; 135(1):14-9. PubMed ID: 12504691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term visual outcomes after vitrectomy for macular edema with foveal hemorrhage in branch retinal vein occlusion.
    Kumagai K; Furukawa M; Ogino N; Larson E; Uemura A
    Retina; 2007 Jun; 27(5):584-8. PubMed ID: 17558320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optic nerve atrophy after vitrectomy with indocyanine green-assisted internal limiting membrane peeling in diffuse diabetic macular edema. Adverse effect of ICG-assisted ILM peeling.
    Ando F; Yasui O; Hirose H; Ohba N
    Graefes Arch Clin Exp Ophthalmol; 2004 Dec; 242(12):995-9. PubMed ID: 15592868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pars plana vitrectomy and internal limiting membrane peeling for macular edema secondary to retinal vein occlusion.
    Baharivand N; Hariri A; Javadzadeh A; Heidari E; Sadegi K
    Clin Ophthalmol; 2011; 5():1089-93. PubMed ID: 21847342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative evaluation of vitrectomy and dye-enhanced ILM peel with grid laser in diffuse diabetic macular edema.
    Kumar A; Sinha S; Azad R; Sharma YR; Vohra R
    Graefes Arch Clin Exp Ophthalmol; 2007 Mar; 245(3):360-8. PubMed ID: 17093998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pars plana vitrectomy and removal of the internal limiting membrane in diabetic macular edema unresponsive to grid laser photocoagulation.
    Yanyali A; Horozoglu F; Celik E; Ercalik Y; Nohutcu AF
    Eur J Ophthalmol; 2006; 16(4):573-81. PubMed ID: 16952097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.